The SEC Reporting and SOX Compliance Manager will be responsible for managing the company's SEC reporting and SOX compliance functions. This role involves ensuring accurate and timely preparation and filing of financial reports with the SEC, as well as developing and maintaining internal controls to ensure compliance with SOX regulations. This role will also be involved in performing technical accounting research and preparing accounting memos. The manager will collaborate with various departments to identify and mitigate risks, ensure accurate financial reporting and support internal and external audits.
Essential Functions and Responsibilities:
- Prepare SEC filings including 10-Ks, 10-Qs, 8-Ks, Annual Proxy statements and other required filings, including review of XBRL tagging.
- Assist with the preparation of financial statements and disclosures.
- Ensure compliance with SEC regulations and US GAAP requirements.
- Assist in the development and implementation of internal controls to ensure compliance with SOX regulations.
- Coordinate annual audit and quarterly review procedures with external auditors by maintaining PBC deliverables, including GAAP checklists, financial statement analytics, related party listings and other items.
- Conduct risk assessments of financial reporting processes and systems.
- Coordinate with business process owners and control owners to ensure compliance with SOX regulations.
- Evaluate control deficiencies and track remediation to completion.
- Provide training and support to stakeholders on internal control requirements, design and ownership.
- Collaborate with external auditors and internal stakeholders to ensure compliance.
- Perform technical accounting research and prepare technical accounting memos for significant contracts, transactions, and implementation of new accounting standards as needed.
- Assist with monthly accounting close duties by preparing certain journal entries and reconciliations as needed.
- Maintain up-to-date knowledge of financial regulations, required processes, and industry standards.
- Other duties as required.
Required Skills/Qualifications:
- Bachelor’s degree in accounting, finance or a related field.
- Active CPA required.
- Minimum of 4 years of relevant work experience within U.S. public companies, public accounting or U.S. public biotechnology, pharmaceutical and/or CRO/CDMO is a must.
- Candidates with direct experience working within a biotechnology or pharmaceutical organization will be given preference.
- Strong understanding of SEC regulations, GAAP and SOX compliance.
- Experience working with financial reporting software (e.g., ActiveDisclosure) and NetSuite preferred.
- Excellent analytical, organizational and communication skills.
- Ability to work collaboratively across departments and manage multiple priorities.
Job Type: Full-time
Benefits:
· 401K
· Medical insurance
· Dental insurance
· Vision insurance
· Supplemental disability insurance plans
· Flexible schedule
· Life insurance
· Flexible vacation
· Sick time
· Incentive stock option plan
· Relocation assistance
Schedule:
· Monday to Friday
Work authorization:
· United States (Required)
Additional Compensation:
· Annual targeted bonus X%
Work Location:
· On site (San Diego, CA)
EQUAL OPPORTUNITY EMPLOYER:
Janux Therapeutics, Inc. is an equal opportunity employer that is committed to providing a work environment free of harassment and discrimination based upon a protected category, as well as an environment free from retaliation for protected activity.
Notice to Recruiters and Third-Party Agencies
The Talent Acquisition team manages the recruitment and employment process for Janux. To protect the interests of all parties involved, Janux will only accept resumes from a recruiter once a fully-executed search agreement is in place. Agencies are hereby specifically directed not to contact Janux employees directly in an attempt to present candidates. Janux will consider any candidate for whom an Agency and/or Recruiter has submitted an unsolicited resume to have been referred, free of any charges or fees.
Top Skills
What We Do
Janux Therapeutics is an innovative biopharmaceutical company developing next-generation therapeutics based on its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to better treat patients suffering from cancer. Janux’s initial focus is on developing a novel class of T cell engagers (TCEs), and its lead product candidates are designed to target clinically validated drug targets. While TCE therapeutics have displayed potent anti-tumor activity in hematological cancers, developing TCEs to treat solid tumors have faced challenges due to the limitations of prior TCE technologies, namely (i) overactivation of the immune system leading to cytokine release syndrome, (ii) on-target, healthy tissue toxicities, and (iii) poor pharmacokinetics leading to short half-life. Janux is using its TRACTr platform technology to engineer product candidates designed to overcome these limitations. Janux is developing a broad pipeline with lead programs targeting prostate-specific membrane antigen (PSMA), epidermal growth factor receptor (EGFR), and trophoblast cell surface antigen 2 (TROP2), with all of its programs currently in the IND-enabling or discovery stage.